Cardiogenesis Corporation
Medical Devices, 1655 Roberts BLVD, Kennesaw, Georgia, 30144, United States, 11-50 Employees
Phone Number: +16*********
Who is CARDIOGENESIS CORPORATION
In May of 2011, CryoLife completed the acquisition of Cardiogenesis Corporation. Now a wholly owned subsidiary of CryoLife, Cardiogenesis specializes in the treatment of cardiovascular di...
Read More
-
Headquarters: 1655 Roberts BLVD, Kennesaw, Georgia, 30144, United States
-
Date Founded: 1989
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3841
|
NAICS Code: 339112 |
Show More
Does something look wrong? Fix it. | View contact records from CARDIOGENESIS CORPORATION
Cardiogenesis Corporation Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Cardiogenesis Corporation
Answer: Cardiogenesis Corporation's headquarters are located at 1655 Roberts BLVD, Kennesaw, Georgia, 30144, United States
Answer: Cardiogenesis Corporation's phone number is +16*********
Answer: Cardiogenesis Corporation's official website is https://cardiogenesis.com
Answer: Cardiogenesis Corporation's revenue is $5 Million to $10 Million
Answer: Cardiogenesis Corporation's SIC: 3841
Answer: Cardiogenesis Corporation's NAICS: 339112
Answer: Cardiogenesis Corporation has 11-50 employees
Answer: Cardiogenesis Corporation is in Medical Devices
Answer: Cardiogenesis Corporation contact info: Phone number: +16********* Website: https://cardiogenesis.com
Answer: In May of 2011, CryoLife completed the acquisition of Cardiogenesis Corporation. Now a wholly owned subsidiary of CryoLife, Cardiogenesis specializes in the treatment of cardiovascular disease and the sale of devices that treat severe angina. Its market leading FDA-approved Holmium: YAG laser system and single use fiber-optic delivery systems are used to perform a surgical procedure known as Transmyocardial Revascularization (TMR). Published long term results demonstrate the efficacy of the TMR treatment in patients suffering from chronic stable angina refractory to medical management, when stenting or bypass surgery is no longer an option in the treatment for angina. The Cardiogenesis laser system is approved by the FDA for distribution in the U.S. and is CE Marked for use in Europe. TMR is accepted as a meaningful therapy and treatment for refractive angina by the American College of Cardiology, American Heart Association and the Society of Thoracic Surgery. In addition, Cardiogenesis is building on the TMR platform in combining laser therapy with the delivery of autologous cell therapy in a single delivery system. As a subsidiary of CryoLife, Cardiogenesis is located in Kennesaw, Georgia a suburb of northwest Atlanta.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month